We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
For products that have a short shelf life and cannot be stockpiled, suppliers should have plans for products to be transported via air freight. Read More
The Senate passed an amendment Thursday to require drugmakers to list prescription drug prices in direct-to-consumer ads in an effort to promote lower prices through increased transparency. Read More
A federal appeals court affirmed last week that Novartis did not engage in antitrust violations to protect a patent on its leukemia drug Gleevec (imatinib). Read More
A coalition of health care stakeholders called on the FDA to issue final guidance on interchangeable biosimilars to help promote drug price competition, saying the agency’s failure to finalize its January 2017 draft guidance created “significant uncertainty.” Read More
Excluding certain patients “limits the ability of a trial to generate data that are relevant to the actual users of the drug,” the experts said. Read More
According to the DOJ, the two doctors distributed or prescribed controlled substances such as Oxycodone, Percocet and steroids illegally to undercover agents. Read More
A panel of experts is urging the FDA to reconsider rigid rules excluding certain groups from clinical trials — or at least make decisions on a case-by-case basis. Read More
In its latest move to combat opioid abuse, the Justice Department slapped two Ohio doctors with restraining orders after a sting operation found they illegally prescribed opioid painkillers and other drugs. Read More